Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
NCT01964963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19192
Last updated 2019-11-21
Summary
The purpose of this study is to examine the safety and efficacy of long-term treatment with alogliptin (Nesina) in patients with mild type 2 diabetes mellitus in the routine clinical setting.
Conditions
Interventions
- DRUG
-
Alogliptin
Alogliptin tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-03
- Primary Completion
- 2017-07-31
- Completion
- 2017-07-31
Countries
- Japan
Study Locations
More Related Trials
-
A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea
NCT04980040 ·Status: COMPLETED
-
Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.
NCT00755846 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
NCT01318135 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.
NCT00655863 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan
NCT01263496 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice
NCT02989649 ·Status: TERMINATED
-
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
NCT01289119 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes
NCT01456130 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
NCT01263509 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan
NCT01318109 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan
NCT01263470 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
NCT01263483 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
NCT00286494 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
NCT01318122 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
NCT00856284 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
NCT00957268 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus
NCT02589639 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
NCT01318070 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
NCT01023581 ·Status: COMPLETED ·Phase: PHASE3
-
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
NCT00461617 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes
NCT00286455 ·Status: COMPLETED ·Phase: PHASE3
-
A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea
NCT04980014 ·Status: COMPLETED
-
Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
NCT01990300 ·Status: COMPLETED
-
Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function
NCT02823808 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus
NCT00286442 ·Status: COMPLETED ·Phase: PHASE3